The FDA has issued recent updates on several drugs that are currently in shortage or have been discontinued:
- Bupivacaine Hydrochloride and Epinephrine Injection, USP (Updated – Currently in Shortage)
- Bupivacaine Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Calcium Gluconate Injection (Updated – Currently in Shortage)
- Cefotetan Disodium Injection (Updated – Currently in Shortage)
- Deferoxamine Mesylate for Injection, USP (Updated – Currently in Shortage)
- Dextrose 5% Injection Bags (Updated – Currently in Shortage)
- Etoposide Injection (Updated – Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Ketorolac Tromethamine Injection (Updated – Currently in Shortage)
- Leucovorin Calcium Lyophilized Powder for Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine (Updated – Currently in Shortage)
- Magnesium Sulfate Injection (Updated – Currently in Shortage)
- Methocarbamol Tablets (New – Currently in Shortage)
- Methotrexate Sodium Injection (Updated – Currently in Shortage)
- Morphine Sulfate Injection, USP (Updated – Currently in Shortage)
- Ondansetron Hydrochloride Injection (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Prochlorperazine Maleate Tablets (Discontinuation)
- Remifentanil (Ultiva) Lyophilized Powder for Solution Injection (Updated – Currently in Shortage)
- Ropivacaine Hydrochloride Injection (Updated – Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated – Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated – Currently in Shortage)
- Sodium Chloride Injection USP, 0.9% Vials and Syringes (Updated – Currently in Shortage)
- Sterile Water (Updated – Currently in Shortage)
- Thioridazine Hydrochloride Tablets (Updated – Currently in Shortage)
- Thiothixene Capsules (Updated – Currently in Shortage)
- Zolpidem Tartrate (Edluar) Sublingual Tablets (Updated – Currently in Shortage)
- Valsartan Tablets (New – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
(Source: U.S. Food & Drug Adminstration)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
